who -COVID-19 infection prevention and control living guideline - mask use in community settings,22 December 2021-此為英文文檔_第1頁
who -COVID-19 infection prevention and control living guideline - mask use in community settings,22 December 2021-此為英文文檔_第2頁
who -COVID-19 infection prevention and control living guideline - mask use in community settings,22 December 2021-此為英文文檔_第3頁
who -COVID-19 infection prevention and control living guideline - mask use in community settings,22 December 2021-此為英文文檔_第4頁
who -COVID-19 infection prevention and control living guideline - mask use in community settings,22 December 2021-此為英文文檔_第5頁
已閱讀5頁,還剩62頁未讀 繼續(xù)免費閱讀

下載本文檔

版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進行舉報或認領(lǐng)

文檔簡介

COVID-19

InfectionPreventionandControl

Livingguideline

Maskuseincommunitysettings

22December2021

WorldHealth

?Organization

WHOInfectionPreventionandControlCOVID-19LivingGuideline-Maskuseincommunitysettings-WorldHealthOrganization(WHO)

2of38

Sections

1.

ExecutiveSummary 3

1.1

Abbreviations 3

1.2

Definitions 4

2.

Methodology 5

3.

Advice,statementsandrecommendations 7

3.1

Generalmaskadvice 7

3.2

Maskuseincommunitysettings 7

3.2.1

Maskuseduringphysicalactivity 15

3.2.2

Typeofmaskusedbythegeneralpublic 16

3.3

Maskusebychildren 22

4.

Acknowledgements 29

References 31

WHOcontinuestomonitorthesituationcloselyforanychangesthatmayaffectthislivingguideline.Shouldanyfactorschange,WHOwillissueafurtherupdate.Otherwise,thislivingguidelinewillexpire2yearsafterthedateofpublication.

?WorldHealthOrganization2021.Somerightsreserved.Thisworkisavailableunderthe

CCBY-NC-SA3.0IGOlicence

.WHOreferencenumber:WHO/2019-nCoV/IPC_masks/2021.1

WHOInfectionPreventionandControlCOVID-19LivingGuideline-Maskuseincommunitysettings-WorldHealthOrganization(WHO)

3of38

1.ExecutiveSummary

InfoBox

Version1.0InfectionPreventionandControlinthecontextofcoronavirusdisease(COVID-19):LivingGuideline

ThisfirsteditionoftheInfectionPreventionandControlinthecontextofcoronavirusdisease(COVID-19):LivingGuidelineprovidesthemostuptodatetechnicalguidanceonmaskuseincommunitysettingsinthecontextofCOVID-19.ThislivingguidelineincorporatestheGradingofRecommendations,Assessment,DevelopmentandEvaluations(GRADE)processes(seeMethodologysection)withexisting(previouslypublished)technicalguidanceinMAGICapptoallowuserstoeasilynavigateinfectionpreventionandcontrol(IPC)guidelinesinthedynamicsituationofCOVID-19.Thiseditiontakesintoconsiderationtheevolvingepidemiologicalsituation,includingtheemergenceoftheVoCOmicron.FurtherinformationonOmicronVoCcanbefoundinthefollowingtechnicaldocumentEnhancingReadinessforOmicron(B.1.1.529):TechnicalBriefandPriorityActionsfortheMemberStates,issuedbyWHOon17December2021[1].

Thisdocumentisalivingguideline,whereupdatedornewstatementswillbeaddedasnewevidenceemergesthatwillbereviewedthroughtheGRADEprocess.Thus,theguidelineiswritten,disseminated,andupdatedinMAGICapp.Itsuser-friendlyformatandstructureallowforeasynavigationwhileaccommodatingforthedynamicnatureoftheCOVID-19publichealthemergencyandassociatedevidenceandrecommendations.MAGICAppallowshighlightingofnewandupdatedstatementswhilekeepingexistingstatementsandsupportingevidencewithintheguideline.Thestatementsaremarkedwithdifferentlabelsandcolourcodingtoreflectthedifferentconsolidationapproachesofexistingguidance,updates,andnewstatements.

Inthisedition,newinformationincludesupdatedmaskrecommendationsforthegeneralpublic,astatementonpoliciesforappropriateadherencetoacomprehensivepackageofpreventivemeasurestoreducesevereacuterespiratorysyndromecoronavirus2(SARS-CoV-2)transmission,astatementonthetypeofmasktobeusedbyhigher-riskindividuals,andimplementationconsiderationsforthetypeandminimumessentialparametersofmasksusedincommunitysettings.

ThepreviouslypublishedtechnicalguidancedocumentsincorporatedinVersion1.0areasfollows:

1.

MaskuseinthecontextofCOVID-19-December2020

;and

2.

AdviceontheuseofmasksforchildreninthecontextofCOVID-19

-August2020;.

TheWorldHealthOrganization(WHO)recommendstheuseofmasksaspartofacomprehensivepackageofpreventionandcontrolmeasurestolimitthespreadofSARS-CoV-2,thevirusthatcausesCOVID-19.Evenwhenusedcorrectly,amaskaloneisinsufficienttoprovideadequateprotectionorsourcecontrol.Otherpublichealthandsocialmeasuresincludetesting,isolation,contacttracing,quarantine,adequateventilationinindoorsettings,aphysicaldistancingofatleast1metre,handhygiene,andrespiratoryetiquette.Together,thesemeasuresarecriticaltopreventhuman-to-humantransmissionofSARS-CoV-2.Thisdocumentguidesdecision-makers,publichealthandIPCprofessionals,childhealthprofessionalsandnon-medicalmaskmanufacturers.

1.1Abbreviations

aOR

adjustedoddsratio

COVID-19

coronavirusdisease2019

CI

ConfidenceInterval

EtD

EvidencetoDecision

GDG

GuidelineDevelopmentGroup

GRADE

GradingofRecommendations,Assessment,DevelopmentandEvaluations

ILI

Influenza-likeillness

IPA

InternationalPaediatricAssociation

IPC

infectionpreventionandcontrol

WHOInfectionPreventionandControlCOVID-19LivingGuideline-Maskuseincommunitysettings-WorldHealthOrganization(WHO)

4of38

NIOSH

NationalInstituteforOccupationalSafetyandHealth

OR

oddsratio

PPE

personalprotectiveequipment

SARS-CoV

severeacuterespiratorysyndromecoronavirus

SARS-CoV-2

severeacuterespiratorysyndromecoronavirus2

UNICEF

UnitedNationsChildren'sFund

UK

UnitedKingdom

USA

UnitedStatesofAmerica

WHO

WorldHealthOrganization

VoC

VariantofConcern

1.2Definitions

Definitions

Healthworkersareallpeopleprimarilyengagedinactionswiththeprimaryintentofenhancinghealth.Examplesarenursingandmidwiferyprofessionals,doctors,cleaners,otherstaffwhoworkinhealthfacilities,socialworkersandcommunityhealthworkers.

Medicalmasksaredefinedassurgicalorproceduremasksthatareflatorpleated,andtheyareaffixedtotheheadwithstrapsaroundtheears,head,orboth.Theirperformancecharacteristicsaretestedaccordingtoasetofstandardizedtestmethods(ASTMF2100,EN14683,orequivalent)thataimtobalancehighfiltration,adequatebreathabilityand,optionally,fluidpenetrationresistance[5][121].

WHOInfectionPreventionandControlCOVID-19LivingGuideline-Maskuseincommunitysettings-WorldHealthOrganization(WHO)

5of38

2.Methodology

Methodologyfordevelopingthestatements

StatementsincludedinthisdocumentarebasedonpublishedWHOguidelines(inparticular,theWHOGuidelinesoninfectionpreventionandcontrolofepidemic-andpandemic-proneacuterespiratoryinfectionsinhealthcare)andongoingevaluationsofallavailablescientificevidencebyWHOCOVID-19IPCGuidanceDevelopmentGroup(GDG)(seeAcknowledgements).Thisevidenceisevaluatedthroughexpeditedsystematicreviewsandexpertconsensus-buildingthroughregularGDGconsultationsfacilitatedbyamethodologist.Whenfurtherclarityorconsensusisnecessary,meetingsarefollowedupbyavotingprocessbytheGDGmembers.Recommendationsarebasedonanassessmentofthebalanceofbenefitstoharmsaswellascertaintyintheseassessments.Thisprocessalsoconsiders,asmuchaspossible,potentialresourceimplications,valuesandpreferences,feasibility,equityandethics.Anexternalreviewpanelofexpertsreviewsdraftguidancedocumentsbeforepublication.

Methodologyfordevelopingthislivingguideline

Asdescribedintheexecutivesummary,giventhedynamicsituationoftheCOVID-19pandemic,thisfirsteditionofthislivingguidelinecombinesexistingguidanceformulatedthroughexpertreviewofevidence,theGRADEevidence-to-decision(EtD)framework,andstandardsfortrustworthyguidelines.ForrecommendationsfollowingtheGRADEEtDframework,aGDGcomprisedofindividualswithbroadexpertisespanningmultiplespecialtiesacrossallWHOregions(seeAcknowledgements)wasconvenedovermultiplemeetingswhereGDGmembersreachedagreement(throughconsensusorvotewithsupermajority)onthestatements.

ManagingConflictsofInterest

AfteranalyzingtheDeclarationofInterestformsandconductingtherequiredinternetsearch,WHOconcludednomemberhadfinancialorcommercialinterestsrelatedtoCOVID-19andmasks.Methodsarealignedwith

WHOHandbookforguidelinedevelopment

.

Readershipcuesforapproachesusedtodevelopstatements

Giventheconsolidationprocess,thestatementsaremarkedwithdifferentlabelsandcolourcodestoreflectthesetwoapproaches.ThegreencheckmarksreflectstatementsthatweredevelopedusingtheGRADEEtDframework.PurplecheckmarksrefertostatementsthathavenotgonethroughtheGRADEEtDframeworkprocessbutareinformedbyevidencereviewandaretheproductofexpertconsensus.Thegreybarreferstoimplementationconsiderationswhichsupportstatementsthroughpracticaladvice,andaretheproductofexpert

consensus.

WHOInfectionPreventionandControlCOVID-19LivingGuideline-Maskuseincommunitysettings-WorldHealthOrganization(WHO)

6of38

GRADEEtDFramework

GRADEratesscientificevidencetodevelopevidence-basedguidelines.Eachrecommendationisassignedastrengthofrecommendationandqualityofevidence.

GRADEevidenceprofilescontainanassessmentofthequalityoftheevidenceandasummaryoffindingsforeachcriticaloutcomeandeachkeyquestion.TheGDGusesthesesummariesasthebasisfordiscussionsandformulationofrecommendations.

Goodpracticestatementsandimplementationconsiderations

Goodpracticestatementsindicateactionsthatshouldbeimplemented,inmostcircumstances,whenthecertaintysurroundingtheeffectestimatesishigh,butthesupportiveevidenceisindirect.Benefitsarebasedonmultiplebodiesofindirectevidence,oftenchallengingtoreviewsystematically.Goodpracticestatementsaregenerallyreservedforconsiderationswithwidespreadconsensusandwhentheinterventioniswidelyaccepted.Implementationconsiderationsarecriticalelementsthatfacilitatetheappropriateuseofformalstatements.

Timeline

AnexternallivingsystematicreviewhasbeencommissionedtocontinuouslymonitoremergingevidenceontheuseofmasksinthecontextoftheCOVID-19publichealthemergencyofinternationalconcern.Theemergingevidencewilltriggercontinuousupdatesastheneedisidentified.

WHOInfectionPreventionandControlCOVID-19LivingGuideline-Maskuseincommunitysettings-WorldHealthOrganization(WHO)

7of38

3.Advice,statementsandrecommendations

3.1Generalmaskadvice

InfoBox

Maskmanagement

Foranytypeofmask,appropriateuse,storage,cleaningordisposalareessentialtoensurethattheyareaseffectiveaspossibleandtoavoidanyincreasedriskoftransmission.Adherencetocorrectmaskmanagementpracticesvaries,reinforcingtheneedforappropriatemessaging[115].WHOprovidesthefollowingguidanceonthecorrectuseofmasks:

?Washhandsthoroughlybeforeputtingonthemask.

?Inspectthemaskfortearsorholes,anddonotuseadamagedmask.

?Placethemaskcarefully,ensuringitcoversthemouthandnose,adjusttothenosebridgeandtieitsecurelytominimizeanygapsbetweenthefaceandthemask.Ifusingearloops,ensurethesedonotcrossoverasthiswidensthegapbetweenthefaceandthemask.

?Avoidtouchingthemaskwhilewearingit.Ifthemaskisaccidentlytouched,washhandsthoroughly.

?Removethemaskusingtheappropriatetechnique.Donottouchthefrontofthemask;rather,untieitfrombehind.

?Replacethemaskassoonasitbecomesdampwithanew,cleananddrymask.

?Eitherdiscardthemaskorplaceitinacleanplasticresealablebagwhereitiskeptuntilitcanbewashedandcleaned.Donotstorethemaskaroundthearmorwristorpullitdowntorestaroundthechinorneck.

?Washhandsimmediatelyafterdiscardingamask.

?Donotreusesingle-usemasks.

?Discardsingle-usemasksaftereachuseandproperlydisposeofthemimmediatelyuponremoval.

?Donotremovethemasktospeak.

?Donotshareyourmaskwithothers.

?Washfabricmasksinsoapordetergentandpreferablyhotwater(atleast60°Centigrade/140°Fahrenheit)atleastonceaday.Ifitisnotpossibletowashthemasksinhotwater,thenwashthemaskinsoap/detergentandroom-temperaturewater,followedbyboilingthemaskfor1minute.

?Amaskshouldbechangedtoacleanmaskatleastoncedaily.

Extractedfromtheguidancetitled“MaskuseinthecontextofCOVID-19”,published1December2020.

Exhalationvalvesonrespiratorsandnon-medicalmasksarediscouragedastheydonotallowforadequatesourcecontrolfromthewearer.Exhalationvalvespermitbypassofthefiltrationlayerswhenthewearerexhales,potentiallyallowingpass-throughofinfectiousparticles.

Extractedfromtheguidancetitled“MaskuseinthecontextofCOVID-19”,published1December2020.

3.2Maskuseincommunitysettings

8of38

InsettingswherethereiscommunityorclustertransmissionofSARS-CoV-2

Updated

Strongrecommendationfor,Moderatecertaintyevidence

InsettingswherethereiscommunityorclustertransmissionofSARS-CoV-2,irrespectiveofvaccinationstatusorhistoryofpriorinfection,wearingawell-fittingmask*thatcoversthenoseandmouthisrecommendedforthegeneralpublicwheninteractingwithindividualswhoarenotmembersoftheirhousehold:

?inindoorsettingswhereventilationisknowntobepoororcannotbeassessed,ortheventilationsystemisnotproperlymaintained,regardlessofwhetherphysicaldistancingofatleast1metrecanbemaintained1;

?inindoorsettingsthathaveadequateventilationifphysicaldistancingofatleast1metrecannotbemaintained*;or

?inoutdoorsettingswherephysicaldistancingofatleast1metrecannotbemaintained*.

*Masktypesinclude:

?reusable,non-medicalmasksthatcomplywiththe

ASTMF3502

standardor

CENWorkingAgreement17553

,oranon-medicalmaskmeetingWHOessentialparameters(seepracticalinfoformoreinformation).;

?disposablemedicalmasks,complyingwithmedicalmaskstandardsEN14683TypeI,ASTMF2100Level1,YY/T0969,YY0469(orequivalent)iftheavailabilityofmedicalmasksmeetingminimumperformancecriteriaforhealthworkershasbeenassured**;

?iftheaboveoptionsarenotavailable,othertypesofwell-fittingnon-medicalmasksincludinghomemademultilayeredmasks***areanacceptableoption(accordingtolocalpolicies).

1Physicaldistanceshouldbeincreasedbeyond1metrewheneverfeasible.

Updated22December2021.

PracticalInfo

Forinformationonassessingandimprovingindoorventilation,pleaseseeWHO's

Roveensureg

oadmaptoimprandoodindoor

venconoCOVID-19

tilationinthetextf.

Practicalconsiderationsforpolicy-makers:

Thepotentialadvantagesofmaskusebyhealthypeopleinthegeneralpublicinclude:

?reducedspreadofpotentiallyinfectiousaerosolsordropletsfromexhaledbreath,includingfrominfectedpeoplebeforetheydevelopsymptoms[15];

?encouragingconcurrenttransmissionpreventionbehaviourssuchaswashinghandsandnottouchingtheeyes,noseandmouth[16][17][18];and

?preventingtransmissionofotherrespiratoryillnessessuchastuberculosisandinfluenzaandreducingtheburdenofthesediseasesduringthepandemic[19].

Thepotentialdisadvantagesofmaskusebyhealthypeopleinthegeneralpublicinclude:

?headacheand/orbreathingdifficulties,dependingonthetypeofmaskused[12];

?developmentoffacialskinlesions,irritantdermatitisorworseningacnewhenusedfrequentlyforlonghours[13][20];

?difficultywithcommunicatingclearly,especiallyforpersonswhoaredeaforhavepoorhearingoruselipreading[21][22];

?poorcompliancewithmask-wearing,inparticularbyyoungchildren[24][25][26][27];

?wastemanagementissues;impropermaskdisposalleadingtoincreasedlitterinpublicplacesandenvironmentalhazards[28];and

?furtherdisadvantagesfor,ordifficultywearingmasksby,certainmembersofthepopulation,especially:children;

WHOInfectionPreventionandControlCOVID-19LivingGuideline-Maskuseincommunitysettings-WorldHealthOrganization(WHO)

9of38

developmentallychallengedpeople;thosewithmentalillnessorcognitiveimpairment;thosewithasthma,chronicrespiratoryorbreathingproblems;thosewhohavehadfacialtraumaorrecentoralmaxillofacialsurgery;andthoselivinginhotandhumidenvironments[12][25].

EvidenceToDecision

Benefitsandharms

Substantialnetbenefitsoftherecommendedalternative

TheutilizationofmasksincommunitysettingsislikelyassociatedwithadecreasedriskofSARS-CoV-2infectionscomparedwithnomask-wearing.SARS-CoV-2B.1.617.2(Delta)varianthasbeenreportedtohaveincreased

transmissibility[29][30][31][33][32];mostGDGmembers,therefore,agreedthat,inthecontextoftheDeltavariant,thebenefitsofmask-wearinginthecommunitysettingoutweighpotentialharms.EcologicalstudieshaveidentifiedanassociationwithdecreasednumberofconfirmedcasesofCOVID-19andpoliciesrequiringtheuseofmasks[34][35][36].Aclusterrandomizedcontrolledtrialevaluatingmaskpromotion(asanindirectpublichealthintervention)foundthatinacountrywithlowmaskuse,maskpromotionincreasedmaskuseanddecreasedsymptomaticSARS-CoV-2seroprevalence[37].Conversely,anotherrandomizedcontrolledtrialfoundnostatisticalsignificanceassociatedwithsurgicalmaskuseandareducedriskofSARS-CoV-2[38].Thestudyprovidedanimpreciseestimateformaskutilizationversenoutilization;however,thestudywasnotdesignedtoevaluatetheeffectivenessofmaskuseforsourcecontrol.

ManyGDGmembersnotethat,eventhoughthecertaintyoftheevidenceismoderate,thereisasubstantialneedforWHOtoproducecohesiveandrobustrecommendations,asthenetbenefitsofmaskusebythegeneralpublicoutweighthepotentialharms.

Moderate

CertaintyoftheEvidence

Balanceofdesirableandundesirableoutcomes.

Preferenceandvalues

Nosubstantialvariabilityexpected

DiscussionswithstakeholdersandIPCGDGmembershaveindicatedageneralpreferencetofavourmaskuseincommunitysettings.ManyGDGmembersnotethat,inthecontextoftheDeltavariantandothervariantsofconcern,maskingisavitalSARS-CoV-2mitigationmeasure.Membersexpressedaneedtodocumentaclearopinionontheuseofmasksincommunitysettings,giventheimpactoflocalandnationalvaluesandpreferencesonIPCpolicies.Giventheavailabilityofmasks,communitymaskingislikelyfeasible.

Resourcesandotherconsiderations

Noimportantissueswiththerecommendedalternative

ManyGDGmembersnotedtheglobalsupplychainformaskmanufacturinghasimprovedandwouldnotposeasevereobstacletocommunitymasking.Thecostofbothmedicalmasksandnon-medical(fabric)masksarerelativelylow,anddonotposeasubstantialbarrierforlow-andmiddle-incomecountries.

Gapsinknowledgeandresearchneeds

Investigationsontheutilizationofmasksinthecommunitysettingareongoing;however,publishedworkhasidentifiedtheneedforcontinuedresearch.Wellconductedobservationalstudiesand/orrandomizedcontrolledtrialsexploringtheuseofmasksversusnomasksinvarioussettings(e.g.indoor,outdoor,ventilationstatus,etc.)wouldfurtherclarifyoutstandinginquiriesconcerningmaskuseincommunitysettings.Inaddition,researchinvestigatingtheuseofmasks(includingtypeofmaskandtransmissionscenarios)inthecontextoftheDeltavariantwouldprovidepowerfulevidenceforfuturerecommendations.However,GDGmembersdiscussedthechallengesassociatedwithobtainingcompellingevidencefromarandomizedcontrolledtrialonbehaviouralinterventions.Furthermore,withtheavailabilityofaSARS-CoV-2inoculation,furtherresearchwillbeneededtoreinforcetheimpactofvaccinationonmaskutilizationincommunitysettings.

WHOInfectionPreventionandControlCOVID-19LivingGuideline-Maskuseincommunitysettings-WorldHealthOrganization(WHO)

10of38

Justification

GDGmemberswereaskedtoevaluatethestrengthoftheproposedrecommendation(strongrecommendationversusconditionalrecommendation).Basedontheavailableevidence,theGRADEprocessandtheEvidencetoDecisionframework,theIPCGDGagreedonastrongrecommendation.TheopinionoftheGDGwassolidifiedviaanonlinesurvey,inwhich82.1%(23/28)ofGDGmembersvotedforastrongrecommendationand17.9%(5/28)votedforaconditionalrecommendation.

New

Goodpracticestatement

InsettingswherethereiscommunityorclustertransmissionofSARS-CoV-2,policiesshouldbedeveloped,strengthenedandimplementedtoencourageappropriateadherencetoacomprehensivepackageofpreventivemeasurestoreducetransmission(ventilation,physicaldistance,handhygiene,andrespiratoryetiquette)includinginparticular,maskadherencebythegeneralpublic.

Updated22December2021.

Justification

GDGmemberswereinitiallyaskedifWHOshoulddevelopastatementontheimportanceofmask-wearingand/orinterventionstoimproveadherencetomask-wearingguidance;however,manymembersthoughtitwasessentialtoconsiderthe“bundle”ofpublichealthsocialmeasuresthatpertaintothegeneralpublic.Theabovegoodpracticestatementwasdeterminedbyanonlinevote,where27GDGmembersresponded,with55.6%(15)votingforthestatementasmentionedabove,whiletheremaining44.4%(12)votedforslightlydifferentwordingforthegoodpracticestatement.

InalltransmissionscenariosofSARS-CoV-2

InfoBox

Updated

Implementationconsideration

Inareaswithknownorsuspectedsporadictransmission,ornodocumentedtransmission,WHOadvisethatdecision-makersshouldapplyarisk-basedapproachfocusingonthefollowingcriteriawhenconsideringtheuseofmasksforthegeneralpublic:

?purposeofmaskuse;

?riskofexposuretoSARS-CoV-2;

?vulnerabilityofthemaskwearer/population;

?settinginwhichthepopulationlives;

?feasibility;

?typeofmask;

?vaccinationcoverage;and

?circulatingvariantsofconcern.

Updated22December2021.

Justification

GDGmembersnotedtheimportanceofincludingvaccinationcoverageandcirculatingvariantsofconcerntotheimplementation

11of38

considerationsgiventheavailabilityofvaccinationandthecurrentlandscapeofSARS-CoV-2transmission.

Inanytransmissionscenario,personswithanysymptomssuggestiveofCOVID-19shouldwearamedicalmaskandadditionally:

?self-isolateandseekmedicaladviceassoonastheystarttofeelunwellwithpotentialsymptomsofCOVID-19(evenifsymptomsaremild);

?followinstructionsonhowtoputon,takeoffanddisposeofmedicalmasksandwashhandsthoroughly[39];

?followalladditionalmeasures,inparticular,respiratoryhygiene,frequenthandwashingandmaintainingaphysicaldistanceofatleast1metrefromotherpersons[75].

?IfamedicalmaskisnotavailableforindividualswithsuspectedorconfirmedCOVID-19,afabricmaskwithfit,filtrationandbreathabilityassessedtomeetWHO'sessentialparametersfornon-medicalmasksshouldbewornbypatientsasasourcecontrolmeasure,pendingaccesstoamedicalmask.Theuseofanon-medicalmaskcanminimizetheprojectionofrespiratoryparticlesfromtheuser[40][41]

AsymptomaticpersonswhotestpositiveforSARS-CoV-2shouldwearamedicalmaskwhenwithothersforaperiodof10daysaftertestingpositive.

Extractedfromtheguidancetitled“MaskuseinthecontextofCOVID-19”,published1December2020.

EvidenceToDecision

CertaintyoftheEvidence

Evidenceontheprotectiveeffectofmaskuseincommunitysettings

Atpresent,thereisonlylimitedandinconsistentscientificevidencetosupporttheeffectivenessofmaskinghealthypeopleinthecommunitytopreventinfectionwithrespiratoryviruses,includingSARS-CoV-2[6].Alargerandomizedcommunity-basedtrialinwhich4862healthyparticipantsweredividedintoagroupwearingmedical/surgicalmasksandacontrolgroupfoundnodifferenceininfectionwithSARS-CoV-2[42].Arecentsystematicreviewfoundninetrials(ofwhicheightwerecluster-randomizedcontrolledtrialsinwhichclustersofpeople,versusindividuals,wererandomized)comparingmedical/surgicalmasksversusnomaskstopreventthespreadofviralrespiratoryillness.Twotrialsinvolvedhealthcareworkersandsevenhadcommunity-basedparticipants.ThereviewconcludedthatwearingamaskmaymakelittleornodifferencetothepreventionofILI(RR:0.99;95%CI:0.82–1.18)orlaboratory-confirmedinfluenza(LCI)(RR:0.91;95%CI:0.66–1.26)[11];thecertaintyoftheevidencewaslowforILI,moderateforLCI.

Bycontrast,asmallretrospectivecohortstudyfromBeijingfoundthatmaskusebyentirefamiliesbeforethefirstfamilymemberdevelopedCOVID-19symptomswas79%effectiveinreducingtransmission(oddsratio(OR):0.21;CI0.06-0.79)[43].Acase-controlstudyfromThailandfoundthatwearingamedicalornon-medicalmaskallthetimeduringcontactwithaCOVID-19patientwasassociatedwitha77%lowerriskofinfection(adjustedoddsratio(aOR)0.23;95%CI0.09–0.60)[44].SeveralsmallobservationalstudieswithepidemiologicaldatahavereportedanassociationbetweenmaskusebyaninfectedpersonandthepreventionofonwardstransmissionofSARS-CoV-2infectioninpublicsettings[2][45][46][47].

Anumberofstudies,somepeer-reviewedbutmostpublishedaspre-prints,reportedadeclineinthenumberofCOVID-19casesassociatedwithfacemaskusebythepublic,usingcountry-orregion-level

data.[48][49][50][51][52][53][54][55][56][57][58][59][60][61][62][63][64][65][66][67][68][69].Onestudyreportedanassociationbetweencommunitymask-wearingpolicyadoptionandincreasedmovement(lesstimeathome,increasedvisitstocommercial

12of38

locations)[23].Thesestudiesdifferedinsetting,datasourcesandstatisticalmethods,andhaveimportantlimitationstoconsider[70],notablythelackofinformationaboutactualexposureriskamongindividuals,adherencetomask-wearingandtheenforcementofotherpreventivemeasures[71][72].

Studiesofinfluenza,ILIandhumancor

溫馨提示

  • 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預覽,若沒有圖紙預覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負責。
  • 6. 下載文件中如有侵權(quán)或不適當內(nèi)容,請與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準確性、安全性和完整性, 同時也不承擔用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。

評論

0/150

提交評論